© 2025 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Incunabulum LLC.
High Tide Earns Spot on TSX Venture 50 for Second Year
High Tide Inc. has once again secured a place on the TSX Venture 50, ranking 21st in 2024. The recognition, which highlights top-performing companies...
GVB Biopharma Launches Facility with 300,000-Kilo Annual Production Capacity
PRINEVILLE, Ore. -- GVB Biopharma, a global producer of cannabinoids, launched its cutting-edge isolation facility, marking a significant leap in production capabilities and efficiency for the...
Decibel Expands General Admission Brand’s International Footprint
CALGARY, AB -- Decibel Cannabis Company Inc., a market leader in cannabis and extract manufactured products, expanded its global footprint by entering into supply and...
Alexander Rabinovich Replaces Ehud Barak as Chairman at InterCure
Barak, who recently celebrated his 83rd birthday, has decided to pursue personal endeavors after six years of service as board chairman.
Hemp Beverage Alliance to Host Hemp Beverage Expo
Trade association Hemp Beverage Alliance will host the Hemp Beverage Expo July 9-11 in Atlanta.
FDA Fast-Tracks PleoPharma’s Investigational New Drug for Mitigation Cannabis Use Disorder Withdrawal
PHOENIXVILLE, Pa. -- The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, PleoPharma Inc.'s investigational new drug (IND) application for...
Report: Synthetic Drugs Masquerading as Hemp Products in California
A new analysis of 104 so-called hemp products from 68 brands sold in California reveals 95 percent of tested products contained chemically synthesized cannabinoids, which are prohibited in California.
SQDC’s fiscal 2024-2025 Q3 Report Shows Comprehensive Income of CAN$40.5M
Tax revenues, in the form of consumer and excise taxes generated by the company's operations, amounted to $72.6 million, $5112.5 million of which is paid to the Québec government and $21.1 million to the federal government.
Aurora Cannabis Eases Patient Access to Medical Cannabis in Australia
Aurora and its subsidiaries removed the concession card requirement for patients to access medical cannabis products bearing the IndiMed brand.
Organigram Reports First Quarter Fiscal 2025 Results
TORONTO -- Organigram Holdings Inc., a leading licensed producer of cannabis, released its results for the first quarter ended December 31, 2024 (“Q1 Fiscal...
